The role of BMI, serum lipid profile molecules and their derivative indexes in colorectal polyps
Author:
Huang Chunyu12, Liang Weipeng13, Sun Yuying13ORCID
Affiliation:
1. 71067 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center , Guangzhou , P.R. China 2. Department of Endoscopy , 71067 Sun Yat-sen University Cancer Center , Guangzhou , P.R. China 3. 71067 Cancer Prevention Center, Sun Yat-sen University Cancer Center , Guangzhou , P.R. China
Abstract
Abstract
Objectives
To investigate the role of body mass index (BMI), serum lipid profile molecules and their derivative indexes in colorectal polyps.
Methods
A total of 352 individuals who underwent colonoscopy at our center were included in this retrospective analysis. Of these, 247 patients without evident abnormalities (control group), while 105 patients diagnosed with colorectal polyps (patient group). Serum lipid profile molecules and their derivative indexes were then compared between the two groups.
Results
The patient group exhibited significantly higher levels of total cholesterol (TC) and apolipoprotein B (ApoB) compared to the control group (p<0.05). In males, the patient group displayed elevated levels of ApoB and ApoB/ApoA1 ratio compared to the control group (p<0.05). Additionally, the triglycerides (TG) and TG/high-density lipoprotein-cholesterol (HDL-C) ratios were significantly higher in the multiple polyps group than in the single polyp group (p<0.05). Furthermore, the HDL-C and HDL-C/ApoA1 ratio levels were higher in the adenomatous polyp group when compared to the non-adenomatous polyp group (p<0.05). Multiple logistic regression analysis indicated that total cholesterol (TC), TG, low-density lipoprotein-cholesterol (LDL-C), TC/HDL-C ratio, TG/HDL-C ratio and LDL-C/HDL-C ratio were risk factors for the occurrence of colorectal polyps (p<0.05). ROC curve analyses revealed that TC, ApoB, and ApoB/ApoA1 ratio were associated with colorectal polyps. No significant difference in BMI between the two groups (p>0.05).
Conclusions
The incidence and progression of colorectal polyps are linked to serum lipid molecules and their derivative indexes. Dyslipidemia may increase the risk of colorectal polyps, potentially leading to colorectal cancer (CRC).
Funder
Guangdong Medical Research Foundation
Publisher
Walter de Gruyter GmbH
Reference36 articles.
1. Segal, E, Prestwood, TR, van der Linden, WA, Carmi, Y, Bhattacharya, N, Withana, N, et al.. Detection of intestinal cancer by local, topical application of a quenched fluorescence probe for cysteine cathepsins. Chem Biol 2015;22:148–58. https://doi.org/10.1016/j.chembiol.2014.11.008. 2. Waniczek, D, Śnietura, M, Młynarczyk-Liszka, J, Pigłowski, W, Kopeć, A, Lange, D, et al.. PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions. Pol J Pathol 2013;64:15–20. https://doi.org/10.5114/pjp.2013.34598. 3. Zauber, AG, Winawer, SJ, O’Brien, MJ, Lansdorp-Vogelaar, I, van Ballegooijen, M, Hankey, BF, et al.. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. New Engl J Med 2012;366:687–96. https://doi.org/10.1056/nejmoa1100370. 4. Chen, H, Zheng, X, Zong, X, Li, Z, Li, N, Hur, J, et al.. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer. Gut 2021;70:1147–54. https://doi.org/10.1136/gutjnl-2020-321661. 5. Rodriguez-Broadbent, H, Law, PJ, Sud, A, Palin, K, Tuupanen, S, Gylfe, A, et al.. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer. Int J Cancer 2017;140:2701–8. https://doi.org/10.1002/ijc.30709.
|
|